טוען...
Can we stop AIDS with antiretroviral-based treatment as prevention?
Challenges to scaling up treatment as prevention (TasP) of HIV transmission are considerable in the developing-world context and include accessing at-risk populations, human resource shortages, adherence and retention in care, access to newer treatments, measurement of treatment effects, and long-te...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Global Health: Science and Practice
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4168559/ https://ncbi.nlm.nih.gov/pubmed/25276515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9745/GHSP-D-12-00053 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|